The emerging therapy of this peptide represents a exciting advance in the handling of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets multiple pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – leading to improved blood sugar control and possible weight loss. Scientists are ex… Read More